Prevalence of target organ damage and factors associated with cardiovascular events in subjects with refractory hypertension;Prevalencia de lesión de órganos diana y factores asociados a la presencia de episodios cardiovasculares en sujetos con hipertensión arterial refractaria

Medicina Clinica

Volumn 133, Issue 4, 2009, Pages 127-131

  Armario, Pedro ^a   Oliveras, Anna ^b   Hernández Del Rey, Raquel ^a   Poch, Esteban ^a   Larrouse, María ^a   Roca Cusachs, Alex ^b   De La Sierra, Alejandro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cardiovascular events; Left atrial enlargement; Left ventricular hypertrophy; Microalbuminuria; Resistant hypertension

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; HEART ATRIUM ENLARGEMENT; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MICROALBUMINURIA; PREVALENCE; STROKE;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; TREATMENT FAILURE; YOUNG ADULT;

EID: 68149141040     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.12.033     Document Type: Article

References (33)

1. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano 2007 Guidelines for the Management of Arterial Hipertensión of the European Society of Hipertensión (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187
2. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, and R.D. Toto Resistant hypertension: Diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
3. C. Cuspidi, G. Macca, L. Sampieri, I. Michev, M. Salerno, and V. Fusi High prevalence of cardiac and extracardiac target organ damage in refractory hypertension J Hypertens 19 2001 2063 2070
4. G.F. Salles, R. Fiszman, C.R.L. Cardoso, and E.S. Muxfeldt Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension Hypertension 50 2007 723 728
5. R. Hernández del Rey, P. Armario, M. Martín-Baranera, P. Sánchez, G. Cárdenas, and H. Pardell Target-organ damage and cardiovascular risk profile in resistant hypertension, influence of white-coat effect Blood Press Monit 3 1998 331 337
6. P. Armario, R. Hernández del Rey, P. Sánchez, M. Martín-Baranera, G. Torres, and J. Juliá Determinants of left ventricular mass in untreated mildly hypertensive subjects. Hospitalet Study in Mild Hypertension Am J Hypertens 12 1999 1084 1090
7. R. Hernández del Rey, P. Armario, M. Martín-Baranera, and P. Castellanos Agrupación de factores de riesgo cardiovascular y prevalencia de síndrome metabólico en sujetos con hipertensión arterial resistente Med Clin (Barc) 127 2006 241 245
8. I.Z. Ben-Dov, J.D. Kark, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure Turing sleep Hypertension 49 2007 1235 1241
9. D. Conen, and F. Bamberg Non invasive 24-h ambulatory blood pressure and cardiovascular disease: A systematic review and meta-analysis J Hypertens 26 2008 1290 1299
10. Sierra C, De la Sierra A, Sobrino J, Segura J, Banegas JR, Gorostidi M, et al. en representación de los Investigadores del Registro Nacional de MAPA. Sociedad Española de Hipertensión. Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Med Clin (Barc). 2007; 129: 1-5.
11. J. Redon, C. Campos, M.L. Narciso, J.L. Rodicio, J.M. Pascual, and L.M. Ruilope Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study Hypertension 31 1998 712 718
12. F.G. Salles, C.R.L. Cardoso, and E.S. Muxfeldt Prognostic influence of office and ambulatory blood pressures in resistant hypertension Arch Intern Med 168 2008 2340 2346
13. C. Calvo, R.C. Hermida, D.E. Ayala, J.E. López, J.R. Fernández, and A. Mojón Efectos de la administración temporalizada de fármacos antihipertensivos en pacientes con hipertensión arterial resistente Med Clin (Barc) 126 2006 364 372
14. E. Rodilla, J.A. Costa, F. Pérez-Lahiguera, C. González, and J.M. Pascual Respuesta antihipertensiva a la espironolactona en pacientes con hipertensión arterial refractaria Med Clin (Barc) 131 2008 406 411
15. ASE Committee Recommendations. Recommendations for Chamber Quantification: Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography. A Branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, and I. Sachs Echocardiographic assessment of left ventricular hypertrophy. Comparison to necropsy findinds Am J Cardiol 57 1986 450 458
17. M.J. Koren, R.B. Devereux, P.N. Casale, D.D. Savage, and J.H. Laragh Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension Ann Intern Med 1145 1991 345 352
18. E. Gerdts, K. Watchtell, P. Omvik, J.E. Otterstad, L. Oikarinen, and K. Boman Left atrial size and risk of major cardiovascular events during antihypertensive treatment. Losartan Intervention for Endpoint Reduction in Hypertension Trial Hypertension 49 2007 311 316
19. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinina: A new prediction equation Ann Intern Med 130 1999 461 470
20. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
21. C. Cuspidi, S. Meani, V. Fusi, C. Valerio, E. Catini, and C. Sala Prevalence and correlates of left ventricular enlargement on essential hypertension: Role of ventricular geometry and the metabolic syndrome J Hypertens 23 2005 875 882
22. E.J. Benjamin, R.B. D'Agostino, A.J. Belanger, P.A. Wolf, and D. Levy Left atrial size and the risk of stroke and death. The Framingham Heart Study Circulation 92 1995 835 841
23. W.P. Abhayarama, J.B. Seward, C.P. Appleton, P.S. Douglas, J.K. Oh, and A.J. Tajik Left atrial size J Am Coll Cardiol 47 2006 2357 2363
24. E. Gerdts, K. Wachtell, P. Omvik, J.E. Otterstad, L. Oikarinen, and K. Boman Left atrial size and risk of major cardiovascular events during antihypertensive treatment. Losartan Intervention for Endpoint Reduction in Hypertension Trial Hypertension 49 2007 311 316
25. C. Gatzka, C.M. Reid, A. Lux, A.M. Dart, and G.L. Jennings for the Hypertension Diagnostic Service Investigator Clin Exp Pharmacol Physiol 26 1999 514 516
26. E. Ratto, G. Leoncini, F. Viazzi, G.P. Bezante, V. Falqui, and A. Parodi Inappropriate left ventricular mass in associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension J Hypertens 26 2008 345 350
27. K. Wachtell, V. Palmieri, M.S. Olsen, J.N. Bella, T. Aalto, and B. Dahlöf Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study Am Heart J 143 2002 319 326
28. P. Palatini, G.R. Graniero, C. Canali, M. Santonastaso, L. Mos, and D. Piccolo Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension J Hypertens 13 1995 1796 1800
29. E.S. Muxfeld, K.V. Bloch, A.R. Nogueira, and G.F. Salles True resistant is possible to recognize in the office? Am J Hypertens 18 2005 1534 1540
30. R.H. Fagard, H. Celis, L. Thijs, J.A. Staessen, D.L. Clement, and M.L. De Buyzere Daytime and night time blood pressure as predictors of death and cause-specific cardiovascular events in hypertension Hypertension 51 2008 55 61
31. M.H. Olsen, K. Wachtell, J.N. Bella, V. Palmieri, E. Gerdts, and G. Smith Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: A LIFE substudy J Hum Hypertens 18 2004 453 459 (Pubitemid 38787041)
32. J. Redón, L. Cea-Calvo, J.V. Lozano, J.C. Martí-Canales, J.L. Llisterri, J. Aznar The Prevención de Riesgo de Ictus (PREV-ICTUS) Study Differences in blood pressure control and stroke mortality across Spain Hypertension 49 2007 799 805
33. R.S. Cooper Using public Health indicators to measure the success of hypertension control Hypertension 49 2007 773 774